| Bioactivity | SARS-CoV-2-IN-89 (Compound 2) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-89 enhances IFN-I responses to SARS-CoV-2 infection in A549.hACE2 cells[1]. |
| CAS | 1016762-41-6 |
| Formula | C17H13FN2O |
| Molar Mass | 280.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zodda E, et al. Induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors. bioRxiv, 2024: 2024.05. 31.596900. |
SARS-CoV-2-IN-89
CAS: 1016762-41-6 F: C17H13FN2O W: 280.30
SARS-CoV-2-IN-89 (Compound 2) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-89 enhances IFN-I responses to SARS-CoV-2 infecti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.